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AbstrACt
Objectives Fibre-endoscopic evaluation of swallowing 
(FEES) to detect dysphagia is gaining more and more 
importance as a diagnostic tool. Therefore, we have 
investigated the impact of FEES in neurological patients in 
a clinical setting.
Design Cross-sectional hospital-based registry.
setting Primary acute care in a neurological department 
of a German university hospital.
Participants 241patients with various neurological 
diseases who underwent FEES procedure.
Primary and secondary outcome measures Dysphagia 
and related comorbidities.
results 267 FEES were performed in 241 patients 
with various neurological diagnoses. Dysphagia was 
diagnosed in 68.9% of the patients. In only 33.1% 
of the patients, appropriate oral diet was chosen 
prior to FEES. A relevant dysphagia occurred more 
often in patients with structural brain lesions (83.1% 
vs 65.3%, P=0.001), patients with dysphagia had a 
longer hospitalisation (median 18 (IQR 12–30) vs 15 
days (IQR 9.75–22.75), P=0.005) and had a higher 
mortality (8.4% vs 1.3%, P=0.041). When the oral diet 
was changed, we observed a lower pneumonia rate 
(36% vs 50%, P=0.051) and a lower mortality (3.7% vs 
11.3%, P=0.043) in comparison to no change of oral 
diet. A restriction of oral diet was identified more often 
in older patients (median 75 years (IQR 66.3–82 years) 
vs median 72 years (IQR 60–79 years), P=0.01) and in 
patients with structural brain lesions (86.8% vs 73.1%, 
P=0.05).
Conclusion On clinical investigation, dysphagia was 
misjudged for the majority of the patients. FEES might help 
to compensate this drawback, revising the diet regime in 
nearly 70% of the patients.
bACkgrOunD 
Dysphagia is a common complication in 
neurological diseases with aspiration pneu-
monia as a leading cause of death in stroke, 
multiple sclerosis, amyotrophic lateral scle-
rosis, Parkinson’s disease or dementia.1–5 In 
elderly patients suffering from infections, a 
concomitant aspiration pneumonia results 
in increased morbidity and mortality.6 7 
Dysphagia determines therefore the imme-
diate prognosis of ill patients, and due 
to the functional link to the central and 
peripheral nerve system, it is of particular 
relevance to neurological patients.7 
Apart from a physical examination 
performed by physicians or speech and 
language therapists, diagnostic tools have 
been developed to investigate the swallowing 
function.8 Two procedures, the videofluo-
roscopic evaluation of swallowing and the 
fibre-endoscopic evaluation of swallowing 
(FEES) have entered the clinical practice 
for this purpose. The latter works without 
radiation exposure and it can be easily 
repeated; it can be performed at bedside 
and even in uncooperative or unconscious 
patients. FEES is therefore gaining more 
and more importance in the examination of 
neurological patients.9 10 However, system-
atic studies providing the overall benefit of 
this procedure in neurological patients are 
currently missing.
Therefore, the aim of the presented study 
is to assess the value of FEES for unselected 
neurological patients regarding the benefit 
of judging the swallowing function and the 
related short-term outcome.
strengths and limitations of this study
 ► Performance of fibre-endoscopic evaluation of 
swallowing  (FEES) by experienced examiners in a 
standardised manner.
 ► Considering the current literature, our study has 
included the highest number (n=241) of neurological 
patients systematically examined with FEES.
 ► Single-centre study, which might lead to a centre-
specific bias in diagnostic and therapeutic measures, 
influencing data acquisition.
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MethODs
FEES has been performed in patients who had a stroke 
with pathological bedside screening examination (BSE). 
In patients with other aetiologies, it has been performed 
when there were pathological findings in the compre-
hensive swallowing examination (CSE) conducted by 
a speech and language therapist (SLT). An indication 
for CSE was a clinical suspicion of dysphagia, that is, in 
patients with newly diagnosed motor neuron disease or 
in those showing clinical signs of dysphagia (eg, wet voice 
and/or coughing when drinking, etc). In our depart-
ment, we use the Gugging Swallowing Screen (GUSS) 
as a BSE for stroke-associated dysphagia. The GUSS 
consists of four subtests. In the first subtest, vigilance, the 
ability to cough and swallowing of saliva are assessed. The 
next three steps evaluate the patient’s ability to safely 
swallow semisolid, liquid and solid food. In each subtest, 
a maximum of five points can be reached. The level of 
points determines the patient’s severity of dysphagia. 
Due to the degree of severity, different diet recommen-
dations are given.11 The screening process is depicted in 
figure 1.
The oral diet prior to FEES was chosen by the attending 
physician and an SLT based on the findings in the 
CSE. In patients who had a stroke, oral diet was chosen 
according to the instructions of the GUSS. For quality 
control reasons, findings gathered in examinations were 
documented systematically. All FEES procedures were 
performed in a standardised manner by experienced 
physicians (see below).
Figure 1 Strobe diagram of screening process and decisions after FEES. BSE, bedside screening examination; CSE, 
comprehensive swallowing examination; FEES, fibre-endoscopic evaluation of swallowing.
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Patients
All patients treated in our department from January 2014 
to September 2016 who underwent FEES were considered 
for the analysis. The data documented in the database 
included: age, sex, length of stay in hospital, diagnosis, 
presence of brain lesions (such as a new or old ischaemic 
stroke, an intracerebral bleeding, a tumour, a cerebral 
atrophy, etc), occurrence of pneumonia (defined as 
a clinical diagnosis of pneumonia; determined by the 
treating physician), treatment in the intensive care unit, 
mortality, presence of dysphagia and type of oral intake 
(before and after FEES). To acquire data and to use them 
for scientific analyses, an ethical approval was obtained 
from the local ethical committee (Justus-Liebig Univer-
sity, Giessen; protocol number 208/16).
Fees
FEES is a videoendoscopic nasolaryngeal swallowing 
study. We performed FEES following the standardised 
FEES protocol according to Langmore12: a small endo-
scope (about 4 mm in diameter) was introduced through 
the inferior nasal meatus and the epipharynx in the meso-
pharynx. Swallowing of saliva and different consistencies 
of food and liquids, penetration, aspiration, localisation 
and amount of residues as well as patients’ reactions 
(such as coughing) were visualised and documented. By 
definition, penetration is entering of any material into 
the airway (above the level of the vocal folds), aspiration 
means entering of any material below the level of the 
vocal folds. In the first step of the procedure, anatomical 
changes, management of saliva and movements of swal-
lowing related structures were assessed. Then, we tested 
pudding-thick consistency (thickened water), normal 
water and solid food. All consistencies were applied three 
times. If one of the consistencies appeared unsafe, we left 
out the corresponding consistence. Based on the findings 
in FEES, the appropriate oral diet was chosen for the 
patients. All FEES procedures were performed or super-
vised by an experienced investigator.
Outcome measurements
Oral intake and the degree of dysphagia severity were 
measured by using the Functional Oral Intake Scale 
(FOIS) and the Fiberoptic Endoscopic Dysphagia Severity 
Scale (FEDSS), respectively.
FOIS is a seven-tiered scale ranging from 1=no oral 
intake at all (NPO=nil per os) to 7=full oral intake 
without restrictions (see online supplementary appendix 
1).13 The data of the functional oral intake scale were 
categorised in either NPO (FOIS=1), partial oral intake 
(FOIS=2–6) or full oral intake (FOIS=7). De-escalation 
of the oral diet was defined as a positive change on the 
FOIS, whereas restriction of the oral diet was defined as a 
negative change.
To define the overall severity of dysphagia, we used the 
FEDSS developed by Dziewas and coworkers.14 The FEDSS 
is a six-tiered scale originally designed to use for patients 
who had a stroke (see online supplementary appendix 2). 
All parameters are recorded in a standardised way.
To evaluate the value of performing FEES in neurolog-
ical patients, the following parameters were correlated 
with baseline data and dependent factors:
 ► Dysphagia as defined by a FEDSS score of ≥2.
 ► Oral intake status as calculated by the FOIS and its 
overall change and type of change after FEES.
statistical analyses
Absolute and relative frequencies were calculated based 
on cross-tables. For comparing relative frequencies, a 
two-tailed Fisher’s exact test was used. Continuous vari-
ables were analysed by calculating the median value and 
the IQR (25% percentile and 75% percentile). Non-para-
metric data were analysed employing the Mann-Whitney 
U test. All statistical analyses were performed with the 
SPSS V.22.0 (IBM Company).
results
Patients’ characteristics
Two hundred and sixty-seven FEES were performed in 
241 patients. In 23 patients (9.5%), the procedure was 
repeated at least once. Among those patients, an improve-
ment of dysphagia was noted in 12 cases (52.1%). The 
subsequent examination revealed an increased severity 
of dysphagia in one patient and in a second patient, 
previously diagnosed with no dysphagia, aspiration was 
detected during a repeated examination.
One hundred and forty patients were male (52.4%), 
the median age was 73 years (IQR 61–80 years). One 
hundred and nine patients (45.2%) were treated on the 
intensive care unit. In 46.8% of the patients, an isch-
aemic stroke was diagnosed. The different disease enti-
ties detected in our patients are summarised in figure 2. 
The group classified as ‘other’ consisted of patients with 
Figure 2 Disease entities detected in patients in percentage 
and absolute.
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heterogeneous diagnoses (epileptic seizures, dementia, 
Guillain-Barré syndrome, degenerative changes of the 
cervical spine, etc).
One hundred and ninety-four patients (80.5%) 
had CT imaging of the brain, 69 (28.6%) underwent 
MRI. Forty-eight patients (19.9%) had both a CT and 
MRI scan, whereas 22 (9.1) patients had no imaging at 
all. One hundred and eighty-seven patients had a brain 
lesion detected in CT scan or MRI (8 tumours, 125 
new ischaemic lesions, 27 bleedings, 27 other lesions 
(old ischaemic lesions, unspecific white matter lesions, 
cortical atrophy, etc)). Ninety-eight patients (40.7%) 
developed pneumonia, 15 patients died during hospital-
isation (6.2%). Initially, 140 patients (52.4%) had NPO, 
58 patients (24.1%) had partial oral intake and 43 
patients (16.1%) had full oral intake. One hundred and 
eight patients (44.8%) were dependent on a nasogastric 
feeding tube prior to FEES and seven patients (2.9%) on 
a percutaneous endoscopic gastrostomy tube. Patients’ 
characteristics are presented in table 1.
No side effects, that is, laryngospasm, syncope or 
non-self-limiting epistaxis occurred, two patients (0.8%) 
had mild epistaxis after FEES.
Fees examination
The median overall FEDSS score of the entire study 
population was 4 (IQR 1–6). FEES revealed no sign of 
dysphagia (FEDSS=1) for 75 patients (31.1%), whereas 
dysphagia (FEDSS 2–6) was diagnosed in 166 persons 
(68.9%).
An oral diet was more often de-escalated in patients 
without dysphagia (72.8% vs 25.3%, P<0.0001) and was 
more often restricted in patients with dysphagia patients 
with a normal swallowing function (2.5% vs 36.6%, 
P<0.001). As for 26 patients (10.8%) with a full oral 
intake, FEES showed a critical dysphagia and as a result, 
the diet was re-evaluated. Out of these 26 patients, 16 
(61.5%) had a partial oral intake and 38.5% patients had 
NPO after FEES. Changes in oral diet after FEES can be 
seen in figure 1.
Patients with brain lesions were more often diagnosed 
with dysphagia (65.3% vs 83.1%, P=0.001). Patients with 
dysphagia stayed longer in hospital (median 15 (IQR 
9.75–22.75) vs 18 (IQR12-30) days, P=0.005) and had a 
higher mortality (8.4% vs 1.3%, P=0.041). Results are 
summarised in table 1.
Differences between patients with a change in the oral diet
A total of 161 patients (66.8%) had a change in the oral 
diet, 93 of them (57.8%) were de-escalated and (42.2%) a 
restriction was necessary in 68 patients. NPO was recom-
mended after the examination in 47 of those 68 patients 
restricted in the oral diet (69.1%). Patients without a 
change of the oral diet had a higher rate of pneumonia 
(40.4% vs 36%, P=0.051) and a higher mortality as 
compared with those with a change in the oral diet (10% 
vs 3.7%, P=0.043). Results are summarised in table 2.
Differences between patients with de-escalation and 
restriction of the oral diet
In the patients with a change in oral diet, a restriction 
of oral diet was indicated more often in older patients 
(median 75 (IQR 66.25–82) years old vs 72 (IQR 60–79), 
P=0.01), in patients who had an ischaemic stroke (64.7% 
vs 46.2%, P=0.025) or patients with any other brain lesion 
(86.8% vs 73.1%, P=0.05) as compared with de-escalation 
of oral diet. There was also a higher mortality in patients 
with restriction in oral diet as compared with de-escalation 
Table 1 Baseline characteristics of neurological patients and differences in patients with and without dysphagia
Total 
cohort (n=241)
Normal swallowing 
function (n=75)
Relevant 
dysphagia (n=166) P
Sex (number of male patients) 140 (58.1%) 41 (54.6%) 99 (59.6%) 0.401
Age (median, IQR) 73 (61–80) 71.5 (59–79.5) 73 (62–81) 0.261
Ischaemic stroke 125 (51.9%) 34 (45.3%) 91 (57.8%) 0.165
Intensive care unit 109 (45.2%) 34 (45.3%) 75 (45.2%) >0.999
Brain lesion 187 (77.6 %) 49 (65.3%) 138 (83.1%) 0.001
Pneumonia 98 (40.7%) 28 (37.3%) 70 (42.2%) 0.481
Length of stay in hospital in days (median, IQR) 17 (11–29) 15 (9.75–22.75) 18 (12–30) 0.005
Death 15 (6.2%) 1 (1.3%) 14 (8.4%) 0.041
Change in oral diet 176 (65.9%) 61 (75.3%) 115 (61.8%) 0.36
  Restriction 70 (26.2%) 2 (2.5%) 68 (36.6%) <0.001
  NPO started 47 (17.6%) 0 (0%) 47 (25.3%)
  De-escalation 106 (39.7%) 59 (72.8%) 47 (25.3%) <0.001
PEG on admission 7 (2.9%) 3 (4%) 4 (2.4%) 0.682
PEG procedure in hospital 49 (20.3%) 14 (18.7%) 35 (21.1%) 0.731
PEG at discharge 54 (22.4%) 17 (22.7%) 37 (22.3%) >0.999
NPO, nil per os (no oral intake); PEG, percutaneous endoscopic gastrostomy tube.
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(7.4% vs 1.1%, P=0.082). Results are summarised in 
table 3.
DisCussiOn
FEES showed relevant dysphagia in 166 (68.9%) of 241 
unselected neurological patients. After performing the 
FEES, the diet was revised in 66.8% of the patients. A 
restriction of oral intake was indicated for predominantly 
elderly patients and those suffering from stroke or those 
with other structural brain lesions. Relevant dysphagia 
was associated with a higher mortality and a longer dura-
tion of hospitalisation.
Different studies identified dysphagia as a strong factor 
associated with the bad outcome in many disorders.1–5 15–17 
Therefore, establishing the right diagnosis with initia-
tion of the appropriate therapeutic measures is of major 
relevance. In this context, FEES seems to be a promising 
tool of identifying patients at risk. With this procedure, a 
considerable number of patients with relevant dysphagia 
resulting in the immediate adjustment of the oral diet 
could be identified. In line with investigations in other 
populations, patients diagnosed with dysphagia in our 
study had a longer period of hospitalisation and a higher 
risk for poor outcome. It can be expected that pneumonia 
is the main complication associated of a poor outcome; 
however, our analysis showed no significant differences 
in pneumonia rates between patients with compared 
with patients without dysphagia. Thus, some other 
factors might determine the development of dysphagia 
in neurological patients. As demonstrated in our study, 
dysphagia was associated with the presence of structural 
brain lesions, which could be attributed to the complexity 
of the swallowing process. Swallowing is controlled and 
regulated by complex supramedullary networks, so brain 
lesions causing a relevant swallowing dysfunction seem to 
be an appropriate finding.18 19
Table 2 Baseline characteristics of neurological patients and differences of patients with and without a change of the oral diet
Total 
cohort (n=241)
No change in oral 
diet (n=80)
Change in oral 
diet (n=161) P
Sex (number of male patients) 140 (58.1%) 45 (56.3%) 95 (59%) 0.782
Age (median, IQR) 73 (61–80) 74.5 (60.25–80.75) 72 (61–80) 0.286
Ischaemic stroke 125 (51.9%) 38 (47.5%) 87 (54%) 0.412
Intensive care unit 109 (45.2%) 43 (53.8%) 66 (41%) 0.074
Brain lesion 187 (77.6 %) 60 (75%) 127 (78.9) 0.515
Pneumonia 98 (40.7%) 40 (50%) 58 (36%) 0.051
Length of stay in hospital in days (median, IQR) 17 (11–29) 17.5 (12–33) 17 (11–26) 0.242
Death 15 (6.2%) 9 (11.3%) 6 (3.7%) 0.043
PEG on admission 7 (2.9%) 5 (6.3%) 2 (1.2%) 0.042
PEG procedure in hospital 49 (20.3%) 17 (21.3%) 32 (19.9%) 0.865
PEG at discharge 54 (22.4%) 20 (25%) 34 (21.1%) 0.515
PEG, percutaneous endoscopic gastrostomy tube.
Table 3 Differences of patients with de-escalation or restriction of the oral diet
Change in oral 
diet (n=161)
De-escalation of 
oral diet (n=93)
Restriction of oral 
diet (n=68) P
Sex (number of male patients) 95 (59%) 55 (59.1%) 40 (58.8%) >0.999
Age (median, IQR) 72 (61–80) 72 (60–79) 75 (66.25–82) 0.01
Ischaemic stroke 87 (54%) 43 (46.2%) 44 (64.7%) 0.025
Intensive care unit 66 (41%) 49 (52.7%) 17 (25%) 0.001
Brain lesion 127 (78.9) 68 (73.1%) 59 (86.8%) 0.05
Pneumonia 58 (36%) 38 (40.9%) 20 (29.4%) 0.183
Length of stay in hospital in days (median, IQR) 17 (11–26) 17 (11.75–27.25) 18 (11–31) 0.95
Death 6 (3.7%) 1 (1.1%) 5 (7.4%) 0.082
PEG on admission 2 (1.2%) 2 (2.2%) 0
PEG procedure in hospital 32 (19.9%) 19 (20.4%) 13 (19.1%) >0.999
PEG at discharge 34 (21.1%) 21 (22.6%) 13 (19.1%) 0.697
PEG, percutaneous endoscopic gastrostomy tube.
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The initial diet regime was maintained after perfor-
mance of FEES for only 33.1% of the investigated patients. 
Despite extensive clinical expertise, the established diag-
nosis regarding the swallowing function was incorrect in 
nearly every second patient; 10.8% of the patients had full 
oral intake although they would have needed a restriction. 
A lack of awareness of dysphagia, the inability of clinical 
examinations and screening tests to detect silent aspira-
tions or methodological reasons might also explain this 
result.2 20 Therefore, our results underline the necessity of 
performing elaborate dysphagia diagnostics on a routine 
basis and they support recent trends implementing FEES 
examination as a standard procedure in severely affected 
neurological patients.
A restriction of an oral diet was indicated more often in 
older patients. The age-related impairment of physiolog-
ical function, also called ‘presbyphagia’ might be respon-
sible for this observation.21 Since the vast majority of 
neurological patients in general are of an advanced age, 
presbyphagia needs to be taken into consideration when 
interpreting FEES findings. A structural brain lesion in 
addition to pre-existing presbyphagia might explain the 
distinct severity of dysphagia in our study group. Mortality 
and pneumonia rate were higher in patients that had no 
change of their oral diet. This might sound surprising at 
first, but this group included, apart from non-dysphagic 
patients, patients that were on a restricted diet or NPO 
based on the results of the BSE, CSE or clinical judge-
ment. The group of NPO patients had severe dysphagia 
and a group of them aspirated saliva, which might explain 
the higher rate of pneumonia and mortality. Those 
complications might have been prevented by intubation 
or tracheotomy, but for most patients, this was not an 
option for the patient or the treating physician. Again, 
this demonstrates the lack of awareness for dysphagia.
A selection bias considering a large number of inten-
sive care patients must be taken into account when inter-
preting our results. Since those patients are more severely 
affected, that is, by stroke, our findings could have overes-
timated the number of neurological patients affected by 
dysphagia, which might also explain the high frequency 
of pneumonia as compared with other researchers.22 
Because of ethical reasons, no control group (without 
FEES) was set up: the risk of pneumonia and pneumo-
nia-related death was considered too high. These are the 
main limitations of the study. However, the study design 
represents the clinical routine with a preselection of 
patients by using a BSE or CSE followed by instrumented 
diagnostics. So far only one study by Bax and coworkers 
has been published about the effect of FEES on the 
outcome in 220 neurological patients.23 However, in this 
study only some patients underwent FEES. Whereas in 
our study, all 241 patients underwent FEES procedure.
COnClusiOns
By implementing FEES, we could detect signs of dysphagia 
in 68.9% of our neurological patients. Dysphagia was 
associated with the presence of a structural brain lesions, 
a higher mortality and a longer duration of hospitalisa-
tion. A change of the oral diet was associated with a lower 
incidence of pneumonia and a lower mortality. Due to 
our findings, only 33.1% of the patients had an adequate 
oral diet. As most screening tests for dysphagia do not 
cover non-stroke patients and cannot detect silent aspi-
ration, using FEES at a low threshold for all neurolog-
ical patients might help identifying patients at risk with 
this safe and fast bedside assessment tool. It ensures 
safety when deciding on the type of the oral intake and 
brings the benefit of a marked reduction in mortality and 
morbidity.
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